Skip to main content

Table 2 Expression of miR-216b-5p in serous epithelial ovarian cancer tissues

From: Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer

   miR-216b-5p   
  Total cases High expression (n = 37) Low expression (n = 58) χ2 P
  n n % n %   
Age (year)       0.074 0.786
Postmenopausal(< 50) 42 17 40.48 25 59.52   
Premenopausal (50) 53 20 37.74 33 62.26   
Tumor stage (FIGO)       2.708 0.258
I-II 21 8 38.10 13 61.90   
III 45 21 46.67 24 53.33   
IV 29 8 27.59 21 72.41   
Histological grade (n = 88)       2.216 0.137
H 72 26 36.11 46 63.89   
L 16 9 56.25 7 43.75   
Nodal status (n)       2.509 0.113
Negative 60 27 45.00 33 55.00   
Positive 35 10 28.57 25 71.43   
Tumor diameter (cm)       1.065 0.587
< 10 cm 30 11 36.67 19 63.33   
10–20 cm 58 22 37.93 36 62.07   
> 20 cm 7 4 57.12% 3 42.88   
Chemotherapy       14.194 0.0001
Chemoresistance 32 4 12.50 28 87.50   
Chemosensitivity 63 33 52.38 30 47.62   
Metastasis       0.1 0.752
Y 19 8 42.11 11 57.89   
N 76 29 38.16 47 61.84